| B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells | |
| Hongyu Zhou; Chunlei Yu; Lingmei Kong; Xiaoliang Xu; Juming Yan; Yingchao Li; Tao An; Liang Gong; Yaxiao Gong; Huifang Zhu | |
| 刊名 | Oncogene
 |
| 2019 | |
| ISSN号 | 1476-5594 |
| URL标识 | 查看原文 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/1818970 |
| 专题 | 四川大学 |
| 作者单位 | 1.6, University of the Chinese Academy of Sciences, Beijing, China 2.0004 3.b, Institute of Materia Medica, School of Pharmacy, North Sichuan Medical College, Nanchong, China 4.grid. 5.000000119573309, grid. 6.e, State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China 7.e, Yunnan Key Laboratory of Natural Medicinal Chemistry, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, China 8.0000000119573309, grid. 9.4472, grid. 10.3, Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education and Yunnan Province, School of Chemical Science and Technology, Yunnan University, Kunming, China |
| 推荐引用方式 GB/T 7714 | Hongyu Zhou,Chunlei Yu,Lingmei Kong,et al. B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells[J]. Oncogene,2019. |
| APA | Hongyu Zhou.,Chunlei Yu.,Lingmei Kong.,Xiaoliang Xu.,Juming Yan.,...&Yan Li.(2019).B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells.Oncogene. |
| MLA | Hongyu Zhou,et al."B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells".Oncogene (2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论